Results 121 to 130 of about 161,460 (213)

Additional file 2: of High-intensity interval training and moderate-intensity continuous training in adults with Crohnâ s disease: a pilot randomised controlled trial

open access: yes, 2019
Summary of recruitment survey data. (DOCX 12 kb)
Tew, Garry   +10 more
openaire   +1 more source

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results [PDF]

open access: yes, 2017
Background: Biological agents, such as infliximab, have transformed the outcomes of patients with immune-mediated inflammatory diseases. The advent of biosimilar treatment options such as CT-P13 promises to improve the availability of biological therapy,
Argüelles Arias, Federico   +7 more
core  

Additional file 3: of Dietary treatment of Crohnâ s disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey

open access: yes, 2017
Survey on Dietary Treatment for Crohnâ s Disease Adult/Carer Version. (PDF 241 kb)
Svolos, Vaios   +10 more
openaire   +1 more source

Additional file 1: of Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn’s disease

open access: yes, 2018
Figure S1. Stacked bar-chart showing the relative abundance of microbial classes across the metagenomic sequencing data. Figure S2. Stacked bar-chart showing the relative abundance of bacterial classes across the 16S rRNA gene sequencing data. Figure S3.
Douglas, Gavin   +11 more
openaire   +1 more source

Steroid-Dependent Crohn’s Disease

open access: yesCanadian Journal of Gastroenterology, 2000
Placebo controlled trials have demonstrated that a tapering course of corticosteroids is an effective therapy for active Crohn’s disease. A populationbased study of 109 patients with Crohn’s disease undergoing their first course of corticosteroids showed
William J Sandborn
doaj   +1 more source

Additional file 1: of The bowel preparation for magnetic resonance enterography in patients with Crohnâ s disease: study protocol for a randomized controlled trial

open access: yes, 2019
SPIRIT checklist. (DOC 117 kb)
Dai, Min   +9 more
openaire   +1 more source

MOESM3 of Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohnâ s disease

open access: yes, 2017
Additional file 3. Hematological abnormalities during autologous hematopoietic stem cell transplantation.
Ruiz, Milton   +9 more
openaire   +1 more source

MOESM1 of Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohnâ s disease

open access: yes, 2017
Additional file 1. Sociodemographic and clinical characteristics.
Ruiz, Milton   +9 more
openaire   +1 more source

Additional file 1: of Multimodal treatment of perianal fistulas in Crohnâ s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial

open access: yes, 2015
Dates of consent of participating centres.
E. De Groof   +39 more
openaire   +1 more source

Additional file 3: of Prognostic biomarkers to identify patients destined to develop severe Crohnâ s disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation

open access: yes, 2016
Draft search strategy to be used for the PUBMED online database. (DOCX 104 kb)
Halligan, Steve   +7 more
openaire   +1 more source

Home - About - Disclaimer - Privacy